Angiogenic Characteristics of Tumor-Associated Dendritic Cells in Ovarian and Breast Cancer Models

Angiogenic Characteristics of Tumor-Associated Dendritic Cells in Ovarian and Breast Cancer Models

Bibliographic Details
Main Author:	Lewis, Deana L.
Language:	English
Published:	Ohio University Art and Sciences Honors Theses / OhioLINK 2016
Subjects:	Biomedical Research Cellular Biology Immunology Breast Cancer Ovarian Cancer Tumors Angiogenesis Mice Flow Cytometry PCR analysis
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=ouashonors1462296303

Similar Items

Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
by: Vera Loizzi, et al.
Published: (2017-09-01)

In vitro and ex vivo evaluation of tumor-derived exosome-induced dendritic cell dysfunction in mouse
by: Wenfeng Zeng, et al.
Published: (2021-03-01)

Dissimilar tumor cell populations in ascitic fluid of ovarian cancer patients
by: E. V. Kaigorodova, et al.
Published: (2020-04-01)

Identification of tumor‐associated macrophage subsets that are associated with breast cancer prognosis
by: Elisabeth Strack, et al.
Published: (2020-12-01)

Dendritic Cell Culture With 2D and 3D Collagen Substrates
by: Sprague, Leslee W.
Published: (2011)

Isolation and separation of murine tumor-associated macrophages (TAMs) subpopulations from orthotopic 4T1 breast tumors
by: Pawel Bieniasz-Krzywiec, et al.
Published: (2021-06-01)

Isolation of tumor-resident CD8+ T cells from human lung tumors
by: Stéphanie Corgnac, et al.
Published: (2021-03-01)

The Significance of Flow Cytometry in Breast Cancer
by: Semra Paydas
Published: (1992-02-01)

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes
by: Milne Katy, et al.
Published: (2012-02-01)

Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites
by: Jakimovska Marina, et al.
Published: (2014-09-01)

Intratumoral Monocyte Transfer to Examine Monocyte Differentiation in the Tumor Microenvironment
by: Samir Devalaraja, et al.
Published: (2020-12-01)

The angiogenic process and cancer
by: Omar López, et al.

Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production in vivo and in vitro
by: Simon Wabitsch, et al.
Published: (2021-06-01)

X chromosome studies and breast and ovarian carcinoma
by: Harbord, Sara Helen Alison
Published: (2007)

X chromosome studies and breast and ovarian carcinoma
by: Harbord, Sara Helen Alison
Published: (2007)

X chromosome studies and breast and ovarian carcinoma
by: Harbord, Sara Helen Alison
Published: (2007)

Differential angiogenic gene expression in TP53 wild-type and mutant ovarian cancer cell lines
by: Brittany Anne Davidson, et al.
Published: (2014-06-01)

Possibilities of investigating intratumoral lymphocyte subpopulations by flow cytometry of tumor core biopsy specimens in patients with breast cancer
by: F. A. Shamilov, et al.
Published: (2014-07-01)

Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer
by: Alyssa A. Hoover, et al.
Published: (2020-10-01)

CIS-platin increases immune activity of monocytes and cytotoxic T-cells in a murine model of epithelial ovarian cancer
by: Daniel Hopkins, et al.
Published: (2021-12-01)

Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes
by: Ruszkowska-Ciastek Barbara, et al.
Published: (2020-06-01)

Optimized protocol for immunophenotyping of melanoma and tumor-bearing skin from mouse
by: Sai Sakktee Krisna, et al.
Published: (2021-09-01)

Micrometastases identification in malignant tumors
by: S. A. Kuznetsov, et al.
Published: (2016-03-01)

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome
by: Kim L. Brunekreeft, et al.
Published: (2020-01-01)

Early diagnosis of breast and ovarian cancers by body fluids circulating tumor-derived exosomes
by: Leyla Norouzi-Barough, et al.
Published: (2020-05-01)

Optical quantification of cellular mass, volume and density of circulating tumor cells identified in an ovarian cancer patient
by: Kevin Gregory Phillips, et al.
Published: (2012-07-01)

IMMUNOHISTROCHEMISTRY AND FLOW CYTOMETRIC CHARACTERISTICS OF INTRATUMORAL LYMPHOCYTES IN OVARIAN SEROUS ADENOCARCINOMA
by: E. V. Zuyeva, et al.
Published: (2014-09-01)

Tumor associated macrophages contribute to tumor progression in ovarian cancer
by: Emily K Colvin
Published: (2014-06-01)

MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells
by: Catharina Melzer, et al.
Published: (2018-10-01)

CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
by: Tongyi Lu, et al.
Published: (2020-09-01)

Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives
by: McClung EC, et al.
Published: (2016-03-01)

Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center
by: Giulia Tasca, et al.
Published: (2020-12-01)

The Use and Enhancement of Anti-Cancer Vaccine Therapy with Low-Toxicity Drugs for the Treatment of HER2 Positive Breast Cancer
by: Oechsle, Crystal Mae
Published: (2019)

Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay
by: Agnieszka Horala, et al.
Published: (2017-01-01)

Selective mediation of ovarian cancer SKOV3 cells death by pristine carbon quantum dots/Cu2O composite through targeting matrix metalloproteinases, angiogenic cytokines and cytoskeleton
by: Daomei Chen, et al.
Published: (2021-03-01)

Lymphocyte subpopulations of bone marrow of breast cancer patients
by: T. A. Grigorieva, et al.
Published: (2015-07-01)

Ovarian Cancer Metastasis to the Breast: A Case Report and Review of the Literature
by: Giuseppe Caruso, et al.
Published: (2020-10-01)

Understanding the role of BRIP1 missense variants in breast and ovarian cancer
by: Moyer, Cassandra L.
Published: (2019)

Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake
by: Poller JM, et al.
Published: (2017-04-01)

CHARACTERISTICS OF CLINICAL COURSE OF METASTATIC AND PRIMARY OVARIAN TUMORS IN COLON CANCER
by: I. A. Dzhanyan, et al.
Published: (2015-05-01)